RxDoctor Payments Data

Jason Ou

Physician Assistant · Phoenix, AZNPI 1295487130

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 608 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,092, more than ten times the $31 reported in 2022. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,912in general payments, 2019–2025

Across 608 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Amgen$1K
  • Lilly USA, LLC$705
  • Novo Nordisk$694
  • Madrigal Pharmaceuticals$566
  • plus $6K from 45 others

What the payments were for

  • Food & beverage$11,912100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,912 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide126$177,412
MounjaroTirzepatide96$105,797
JardianceEmpagliflozin30$43,587
Synjardy XrEmpagliflozin/Metformin Hcl52$39,033
FarxigaDapagliflozin Propanediol16$22,651
JanuviaSitagliptin Phosphate15$22,081
Xigduo XrDapaglifloz Propaned/Metformin14$17,101
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$10,957
Tresiba Flextouch U-200Insulin Degludec11$6,527
Nano 2nd Gen Pen NeedlePen Needle, Diabetic32$2,658
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$2,426
Rosuvastatin Calcium129$1,660
Olmesartan Medoxomil76$1,504
SynthroidLevothyroxine Sodium26$1,452
Atorvastatin Calcium188$1,218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$694$177,412126 claims
Lilly USA, LLCMounjaro$705$105,79796 claims
Boehringer IngelheimJardiance, Synjardy Xr$152$82,62082 claims
AstraZenecaFarxiga$1,245$22,65116 claims
GSKTrelegy Ellipta$212$10,95718 claims
AbbVieSynthroid$1,981$1,45226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →